BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32856866)

  • 1. Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.
    Moussa M; Badawy A; Helal N; Hegab F; Youssef M; Aboushousha T; Al Faruok L; Elwy D
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2357-2366. PubMed ID: 32856866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.
    Seo AN; Kwak Y; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2014; 9(5):e98528. PubMed ID: 24879338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
    Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
    Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients.
    Wang J; Hollingshead J; El-Masry N; Horncastle D; Talbot I; Tomlinson I; Alison MR; El-Bahrawy M
    J Gastrointest Cancer; 2012 Sep; 43(3):444-55. PubMed ID: 21989899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.
    Cenaj O; Ligon AH; Hornick JL; Sholl LM
    Am J Clin Pathol; 2019 Jun; 152(1):97-108. PubMed ID: 31115453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
    Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
    Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
    Li JQ; Wu F; Masaki T; Kubo A; Fujita J; Dixon DA; Beauchamp RD; Ishida T; Kuriyama S; Imaida K
    Int J Oncol; 2004 Jul; 25(1):87-95. PubMed ID: 15201993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
    Sherif MF; Ismail IM; Ata SMS
    Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
    Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
    Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas.
    Reis H; Herold T; Ting S; Worm K; Huber U; Christoph DC; Eberhardt WE; Kostbade K; Kasper S; Stamatis G; Welter S; Darwiche K; Karpf-Wissel R; Theegarten D; Schmid KW; Schuler M; Wiesweg M
    Lung Cancer; 2015 Apr; 88(1):34-41. PubMed ID: 25708529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colitis-associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy.
    Iwaya M; Hayashi H; Nakajima T; Matsuda K; Kinugawa Y; Tobe Y; Tateishi Y; Iwaya Y; Uehara T; Ota H
    Histopathology; 2021 Aug; 79(2):227-237. PubMed ID: 33590909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.
    Thompson SK; Sullivan TR; Davies R; Ruszkiewicz AR
    Ann Surg Oncol; 2011 Jul; 18(7):2010-7. PubMed ID: 21267790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
    Nadaf AS; Rani H; Dinesh US
    Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer.
    Liu F; Ren C; Jin Y; Xi S; He C; Wang F; Wang Z; Xu RH; Wang F
    Virchows Arch; 2020 Mar; 476(3):391-398. PubMed ID: 31720832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
    Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
    Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.